Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Ocellaris Pharma, Inc.
Kezar Life Sciences, Inc.
Regeneron Pharmaceuticals
Transgene
Tempus AI
Incyte Corporation
Pfizer
NuCana plc
University of California, San Diego
Lyell Immunopharma, Inc.
NRG Oncology
M.D. Anderson Cancer Center
ImmunoGenesis
Kymab Limited
Incyte Corporation
Fred Hutchinson Cancer Center
University of California, San Diego
Immodulon Therapeutics Ltd
Pfizer
National Cancer Institute (NCI)
Pfizer
Clinigen, Inc.
The Methodist Hospital Research Institute
Seagen Inc.
Nektar Therapeutics
Columbia University
Repertoire Immune Medicines
Idera Pharmaceuticals, Inc.
Incyte Corporation
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celgene
Aprea Therapeutics
National Institutes of Health Clinical Center (CC)
Adaptimmune
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)